According to the research report titled ‘Global Rat and Mouse Model Market Size study, by Type (Knockout, Knock-in, Outbred, Inbred, Others), By Technology (Nuclear transferase, Microinjection, Embryonic stem cells, CRISPR/Cas9, Others) By Service (Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine depending, Others), By Application (Cardiovascular diseases, Genetic diseases, Cancer, Infectious diseases, Transplantation, Toxicology studies, Others), By End-use (Pharmaceutical companies, Academic and research facilities, Biotechnology companies, Contract research & manufacturing organizations) and Regional Forecasts 2021-2027’, available with MarketStudyReport, global rat and mouse model market was valued at USD 1.9 billion in the year 2020, and  is expected to bolster at a CAGR  of 5.5%, reaching a valuation of USD 2.8 billion by the end of the forecast period 2021-2027.
 

The rising adoption of rat & mouse models for pharmaceutical approaches & precision medicine, coupled with rise in the number of research activities in medical sector are primarily contributing towards the expansion of global rat and mouse model market.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566349/
 

Moreover, widespread adoption of rodent models is likely to create lucrative opportunities for enterprises in this line of work.
 

For the unversed, rat and mouse models are used in testing and other medical approaches as they closely resemble the genetic structure of the human population.
 

Despite the positive outlook, ethical values revolving around use of animals for research purposes are likely to hinder industry progression during the review period.
 

Speaking of the regional terrain, North America rat and mouse model market is poised to garner a significant revenue share during the assessment timeframe, given the rising research & development activities in pharma sectors across the region.
 

In the meantime, Asia Pacific market is predicted to record a considerable growth rate during the analysis period, due to massive research activities being conducted for  drug discovery coupled with the immense efforts undertaken for adoption of rodent models in the region.
 

The competitive environment of global rat and mouse model industry is defined by market players like Transpogen Biopharmaceutical, Inc., Charles River Laboratories Inc., Biomedical Research Models Inc. (Biomere), The Jackson Laboratory, Laboratory Corporation of America Holdings (Covance), Janvier Labs, PerkinElmer, Inc., Horizon Discovery Ltd., Envigo RMS LLC, and GenOway among others.